ABDELRAHMAN, GAMALELDEIN FATHY ABDELLATEF
ABDELRAHMAN, GAMALELDEIN FATHY ABDELLATEF
Curcumin-loaded solid lipid nanoparticles bypass p-glycoprotein mediated doxorubicin resistance in triple negative breast cancer cells
2020-01-01 Abd-Ellatef G.-E.F.; Gazzano E.; Chirio D.; Hamed A.R.; Belisario D.C.; Zuddas C.; Peira E.; Rolando B.; Kopecka J.; Marie M.A.S.; Sapino S.; Fahmy S.R.; Gallarate M.; Abdel-Hamid A.-H.Z.; Riganti C.
Different Strategies to Increase Doxorubicin Efficacy in Drug Resistant Cancer Cells Based on Physical, Natural and Pharmacological Approaches
2020-03-31
Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein
2022-01-01 ABDELRAHMAN Gamaleldein; Gazzano E.; El-Desoky A.H.; Hamed A.R.; Kopecka J.; Belisario D.C.; Costamagna C.; S. Marie M.A.; Fahmy S.R.; Abdel-Hamid A.-H.Z.; Riganti C.
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer
2018-01-01 Salaroglio, Iris C; Gazzano, Elena; Abdullrahman, Ahmad; Mungo, Eleonora; Castella, Barbara; Abd-Elrahman, Gamal Eldein Fathy Abd-Ellatef; Massaia, Massimo; Donadelli, Massimo; Rubinstein, Menachem; Riganti, Chiara; Kopecka, Joanna
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance
2017-01-01 Chegaev, Konstantin; Fraix, Aurore; Gazzano, Elena; Abd Ellatef, Gamal Eldein F.; Blangetti, Marco; Rolando, Barbara; Conoci, Sabrina; Riganti, Chiara; Fruttero, Roberta; Gasco, Alberto; Sortino, Salvatore
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Curcumin-loaded solid lipid nanoparticles bypass p-glycoprotein mediated doxorubicin resistance in triple negative breast cancer cells | 2020 | Abd-Ellatef G.-E.F.; Gazzano E.; Chirio D.; Hamed A.R.; Belisario D.C.; Zuddas C.; Peira E.; Rolando B.; Kopecka J.; Marie M.A.S.; Sapino S.; Fahmy S.R.; Gallarate M.; Abdel-Hamid A.-H.Z.; Riganti C. | |
| Different Strategies to Increase Doxorubicin Efficacy in Drug Resistant Cancer Cells Based on Physical, Natural and Pharmacological Approaches | 2020 | - | |
| Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein | 2022 | ABDELRAHMAN Gamaleldein; Gazzano E.; El-Desoky A.H.; Hamed A.R.; Kopecka J.; Belisario D.C.; Costamagna C.; S. Marie M.A.; Fahmy S.R.; Abdel-Hamid A.-H.Z.; Riganti C. | |
| Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer | 2018 | Salaroglio, Iris C; Gazzano, Elena; Abdullrahman, Ahmad; Mungo, Eleonora; Castella, Barbara; Abd-Elrahman, Gamal Eldein Fathy Abd-Ellatef; Massaia, Massimo; Donadelli, Massimo; Rubinstein, Menachem; Riganti, Chiara; Kopecka, Joanna | |
| Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance | 2017 | Chegaev, Konstantin; Fraix, Aurore; Gazzano, Elena; Abd Ellatef, Gamal Eldein F.; Blangetti, Marco; Rolando, Barbara; Conoci, Sabrina; Riganti, Chiara; Fruttero, Roberta; Gasco, Alberto; Sortino, Salvatore |